The transaction includes an initial upfront payment in addition to committed R&D payments. Ambrx will also be eligible to receive future milestone payments associated with research, development and
The patent is entitled ‘methods for introducing heterologous cells into fish’. In addition, neurons, chondrocytes, renal and hepatic cells can be transplanted in zebrafish and effects of growth
The trial data has been submitted to the Chinese State Food and Drug Administration (SFDA) as the final step in securing agency approval to market Microcyn-based products in
Under the terms of the new agreement, HCL will provide strategic support to Merck’s key IT initiatives. Shami Khorana, president, HCL America, said: “We are delighted to take
GlaxoSmithKline (GSK) has completed a bioequivalence study of the formulation in August 2007 and if approved, expects to launch the product in late 2008 in the US. Eurand
The trial was designed to explore the safety and tolerability of PBT2, and its effects on the mechanism and progression of the disease, by investigating biomarkers of Alzheimer’s
Nastech’s intellectual property estate includes rights to issued and pending patent applications relating to RNA-based therapeutics which have broad claims on their development, delivery and use in treating
The technology protected under the patent relates to specific methods for enhancing antigen-specific T-helper cell stimulation using small synthetic peptides. Both prophylactic and immunotherapeutic vaccine peptides are currently
Ethicon Endo-Surgery has agreed to pay Cyberonics a signing fee of $9.5 million and royalties on commercial sales of products covered by the subject patents. Dan Moore, president
Kuvan is an oral small molecule for the treatment of phenylketonuria (PKU) developed in partnership with Merck Serono. The terms of the agreement specify a reduction in royalties
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.